Literature DB >> 12055597

Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.

Martin Wagner1, Christoph K Weber, Frank Bressau, Florian R Greten, Volker Stagge, Matthias Ebert, Steven D Leach, Guido Adler, Roland M Schmid.   

Abstract

BACKGROUND & AIMS: The epidermal growth factor (EGF) receptor family and the corresponding ligands are frequently overexpressed in pancreatic cancer. To compare the biological effects of transforming growth factor (TGF)-alpha and amphiregulin (AR) on growth and differentiation of the exocrine pancreas, we have generated transgenic mice overexpressing AR under control of the elastase promoter.
METHODS: Two independently generated transgenic mouse lines overexpress 50-, 43-, 28-, 26-, and 16-kilodalton AR forms in the pancreas.
RESULTS: Morphologic and immunohistochemical examinations suggest that small intralobular duct and centro-acinar cells proliferate in response to AR in these mice. AR transgenic mice display increased Ras, Erk1/2, cyclin D/CDK4, and cyclin E/CDK2 activity and G1/S progression in pancreatic duct cells. In contrast to TGF-alpha transgenic mice, AR neither induced tubular complex formation nor elicited a strong fibrogenic response. AR induced a slight induction of ErbB2 on duct cells, whereas TGF-alpha resulted in overexpression of the EGF receptor in cells within tubular complexes. Furthermore, AR and TGF-alpha displayed different effects on differentiation of isolated acini in vitro comparable to the situation in vivo.
CONCLUSIONS: These data suggest that AR induces a mitogenic response selectively in small duct cells through activation of Ras, CDK2, and CDK4, respectively. The closely related EGF receptor ligands, AR and TGF-alpha, display different biological effects when overexpressed in the exocrine pancreas in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055597     DOI: 10.1053/gast.2002.33594

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2.

Authors:  Tamara Aleksic; Bernd Baumann; Martin Wagner; Guido Adler; Thomas Wirth; Christoph K Weber
Journal:  Gut       Date:  2006-07-26       Impact factor: 23.059

4.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

5.  Ready, set, go: the EGF receptor at the pancreatic cancer starting line.

Authors:  Rushika M Perera; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

6.  Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice.

Authors:  Jing Xu; Florence Gattacceca; Mansoor Amiji
Journal:  Mol Pharm       Date:  2013-04-16       Impact factor: 4.939

7.  The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent.

Authors:  Kathrin Hedegger; Franziska Stumpf; Helmut Blum; Alexander Graf; Roland Michael Schmid; Marina Lesina; Hana Algül; Marlon Roberto Schneider; Maik Dahlhoff
Journal:  J Gastroenterol       Date:  2019-08-27       Impact factor: 7.527

8.  The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.

Authors:  Altaf Mohammed; Naveena B Janakiram; Qian Li; Venkateshwar Madka; Misty Ely; Stan Lightfoot; Howard Crawford; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2010-11

9.  Epidermal growth factor receptor regulates pancreatic fibrosis.

Authors:  Stacy A Blaine; Kevin C Ray; Kevin M Branch; Pamela S Robinson; Robert H Whitehead; Anna L Means
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-16       Impact factor: 4.052

10.  Pancreatic duct replication is increased with obesity and type 2 diabetes in humans.

Authors:  A E Butler; R Galasso; A Matveyenko; R A Rizza; S Dry; P C Butler
Journal:  Diabetologia       Date:  2009-10-21       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.